DRKS00018809招募中不适用
A post market clinical follow-up study with the aneXys ceramys inlay DE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 75 Years(—)
- 性别
- All
入选标准
- •Participants fulfilling all of the following inclusion criteria are eligible for the study:
- •- Informed consent form (signed by participant and investigator)
- •- Primary implantation
- •- Suffer from primary or secondary osteoarthritis of the hip, femoral head and neck fractures or necrosis of the femoral head. In all cases a stable anchoring of the implant has to be possible.
- •- Age at inclusion: between 18 and 75 years old
- •- Willing to participate in the follow-up examinations mentioned above
- •- Complete recovery is expected
排除标准
- •The presence of any one of the following exclusion criteria will lead to exclusion of the participant:
- •- Missing informed consent form (signed by participant and investigator)
- •- Known or suspected non-compliance (e.g. drug or alcohol abuse)
- •- Enrolment of the investigator, his/her family, employees and other dependent persons
- •- Patients younger 18 years old
- •- Revision surgery
- •- Presence of sepsis or malignant tumours
- •- ASA (American Society of Anesthesiologists) Classification >3
- •- Pregnancy
研究者
相似试验
已完成
不适用
A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlayM16.1M16.7Other primary coxarthrosisOther secondary coxarthrosisDRKS00021508Mathys AG Bettlach150
已完成
不适用
Post-market clinical follow-up study evaluating the efficacy and safety of the wearable cardioverter-defibrillator (WCD) medical device 'LifeVest' in real-life settings in FranceISRCTN91372291ZO550
招募中
4 期
Thigh bone fracture and its union by using different implants studyCTRI/2024/01/061265Auxein Medical Pvt Ltd
已完成
4 期
A post market clinical follow up study of Sterile Hydroxy Propyl Methyl Cellulose Eye DropsCTRI/2024/02/062930Amanta Healthcare Limited65
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations- Hypromellose plus Sodium Hyaluronate Eye Drops.CTRI/2022/07/043789STERICON PHARMA PRIVATE LIMITED54
